Karl Kuusik

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Randomized Controlled Trial

Subarachnoid Hemorrhage

Patient Reported

Top Venues

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Karl Kuusik, Teele Kasepalu, Mihkel Zilmer, Jaan Eha, Kaido Paapstel, Kalle Kilk, Aune Rehema, Jaak Kals
Effects of RIPC on the Metabolomical Profile during Lower Limb Digital Subtraction Angiography: A Randomized Controlled Trial. Metabolites 13 (7) (2023)
Karl Kuusik, Teele Kasepalu, Mihkel Zilmer, Jaan Eha, Mare Vähi, Liisi Anette Torop, Jüri Lieberg, Jaak Kals
The Role of RIPC in Preventing Organ Damage, Inflammation, and Oxidative Stress during Lower Limb DSA: A Randomised Controlled Trial. Oxidative medicine and cellular longevity 2021 (2021)